Results 61 to 70 of about 26,059 (187)
Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars.
Seminars in Oncology, 2014 Biologics are important treatments for a number of cancers, but they are also significant drivers of globally escalating healthcare costs. Biosimilars have the potential to offer cost-savings with comparable efficacy and safety to innovator products ...
D. Henry, C. Taylor
semanticscholar +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Introduction Non‐anesthesiologist‐administered propofol (NAAP) sedation for outpatient endoscopy has proven to be safe. However, implementing NAAP in Western countries faces challenges, and propofol‐based sedation is still largely administered by anesthetists.
Francesco Vito Mandarino +16 more
wiley +1 more source
Pharmacoeconomics of Antibiotic Therapy
Canadian Journal of Infectious Diseases, 1994 During the past few years new drugs with greatly improved efficacy have become available to physicians and their patients. The higher purchase price of these new drugs is quite important and is quoted as a significant cause of the escalating cost of ...
Jacques Le Lorier
doaj +1 more source
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2014 BACKGROUND A postoperative troponin leak that was previously considered clinically insignificant has been independently associated with 30-day mortality in unselected surgical patients ≥45 years of age following non-cardiac surgery.
A. Torborg +3 more
semanticscholar +1 more source
MedComm, Volume 7, Issue 4, April 2026.CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley +1 more source
Differences in drug use between men and women: an Italian cross sectional study
BMC Women's Health, 2017 Background Drugs are the most important treatment option for most diseases, and the majority of medical consultations result in a prescription. Women and men receive different drug prescriptions and differ in therapeutic response to pharmacological ...
Daria Putignano +5 more
doaj +1 more source
Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain.
Asian Pacific Journal of Cancer Prevention, 2014 OBJECTIVE To analyze cost-effectiveness of morphine, MS contin and oxycodone in the treatment of cancer pain, providing guidance for rational drug use in the clinic.
Wen-Zhou Zhang +3 more
semanticscholar +1 more source
Pharmacoeconomics guidelines: The need of hour for India
International Journal of Pharmaceutical Investigation, 2014 Although the government pays for approximately 20% of drugs used in India, private out-of-pocket expenditure in India on health-care is one of the highest in the world.
S. Oberoi, Avneet Oberoi
semanticscholar +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Molecular Oncology, Volume 20, Issue 3, Page 611-628, March 2026.Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
ANALYSIS OF THE COST OF THE DISEASE — PROBLEMS AND SOLUTIONS
Педиатрическая фармакология, 2011 The article discusses the estimation of the disease value, which includes direct, indirect and «intangible» costs. Advantages and disadvantages of different approaches to cost accounting, including the method of direct costs microcalculation compared ...
V.V. Omel'yanovskii +3 more
doaj +2 more sources